ArticlePLOS digital health2026
Equiflow: An open-source software package for evaluating changes in cohort composition.
Article in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Clinical research studies routinely apply exclusion criteria and data preprocessing steps that can substantially alter dataset composition, potentially introducing hidden biases that affect validity and generalizability. This is particularly important in artificial intelligence/machine learning (AI/ML) studies where models learn patterns directly from training data. We developed Equiflow, an open-source Python package that automates creation of enhanced participant flow diagrams tracking both sample size and composition changes throughout studies. Equiflow quantifies distributional shifts at each exclusion step and generates visualizations showing how key clinical and demographic variables evolve during participant selection. In a case study of sepsis patients from the eICU database, sequential exclusions reduced the sample from 126,750-1,094 patients. Requiring non-missing troponin measurements in the final step of data processing caused substantial demographic shifts that would typically remain invisible in traditional reporting. By making compositional biases visible during cohort construction before modeling begins, Equiflow enables researchers to make informed decisions about analyses and acknowledge limitations in generalizability to their readers. This standardized, open-source approach promotes transparency in clinical research and supports development of more equitable clinical AI systems, addressing a critical need as healthcare increasingly relies on data-driven decision making.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.